From 2011 to 2016, increase in invasive MRSA cases from 4.1 to 9.2 percent among injection drug users.
Hospitals that were penalized for high preventable error rates will have their Medicare payments lowered by 1% over the fiscal year.
Incidence rates of MRSA, CD and MDR gram-negative organisms were also lower with ultraviolet environmental disinfection.
Intravenous antibiotic can treat MRSA as well as other serious skin infections.
Study provides evidence to support decontamination strategies for patients with MRSA.
Invasive MRSA infection disproportionately affects young infants and black children.
Genomic sequencing confirmed outbreak and MRSA carriage in case study that involved infants in a special-care baby unit, their mothers and a hospital employee.
Skin abscess can be frustrating and confusing for patients, and the incidence of MRSA continues to grow.
Despite the overall positive impact, some hospitals are spending less time on infections not targeted in the CMS rule.
Drug-resistant Staphylococcus aureus identified in 69% of Chicago-area ambulances.
The number of hospital-acquired MRSA infections is down; however, community-acquired MRSA infections continue to rise.
Clindamycin therapy resulted in fewer recurrences and treatment failures among children with skin and soft tissue infections vs. trimethroprim-sulfamethoxazole or beta-lactam antibiotics.
Research shows that universal nasal surveillance, contact precautions and hand hygiene can reduce hospital-associated methicillin-resistant Staphylococcus aureus transmission.